Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04WBU
|
|||
Former ID |
DNC011877
|
|||
Drug Name |
1-Ethyl-3-methyl-3,7-dihydro-purine-2,6-dione
|
|||
Synonyms |
1-Ethyl-3-methylxanthine; CHEMBL24107; 1-ethyl-3,7-dihydro-3-methyl-1H-purine-2,6-dione; 37102-58-2; 1-Ethyl-3-methyl-3,7-dihydro-purine-2,6-dione; SCHEMBL7016029; KVSRUALMCYFLEP-UHFFFAOYSA-N
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C8H10N4O2
|
|||
Canonical SMILES |
CCN1C(=O)C2=C(N=CN2)N(C1=O)C
|
|||
InChI |
1S/C8H10N4O2/c1-3-12-7(13)5-6(10-4-9-5)11(2)8(12)14/h4H,3H2,1-2H3,(H,9,10)
|
|||
InChIKey |
KVSRUALMCYFLEP-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Adenosine A2a receptor (ADORA2A) | Target Info | Inhibitor | [1] |
KEGG Pathway | Rap1 signaling pathway | |||
Calcium signaling pathway | ||||
cAMP signaling pathway | ||||
Neuroactive ligand-receptor interaction | ||||
Vascular smooth muscle contraction | ||||
Parkinson's disease | ||||
Alcoholism | ||||
Pathwhiz Pathway | Intracellular Signalling Through Adenosine Receptor A2a and Adenosine | |||
Pathway Interaction Database | HIF-2-alpha transcription factor network | |||
Reactome | NGF-independant TRKA activation | |||
Adenosine P1 receptors | ||||
G alpha (s) signalling events | ||||
Surfactant metabolism | ||||
WikiPathways | Nucleotide GPCRs | |||
Monoamine Transport | ||||
GPCRs, Class A Rhodopsin-like | ||||
NGF signalling via TRKA from the plasma membrane | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
GPCRs, Other |
References | Top | |||
---|---|---|---|---|
REF 1 | Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors. J Med Chem. 1986 Jul;29(7):1305-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.